Premier Research and Centogene have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment, thereby increasing the likelihood of study success.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CNTG:
- CENTOGENE Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting and Fierce JPM Week in San Francisco
- CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
- CENTOGENE Receives Nasdaq Non-Compliance Notice
- Centogene receives Nasdaq non-compliance notice
- CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan